Genostics®


Genostics® is medical diagnostic, education and consultancy company.

Genostics® partners with world-class cancer research laboratories in Europe to bring the very best in personalised cancer testing medical communities worldwide.

We engage with pioneering practitioners who seek to discover the exact nature of each patient's cancer. These practitioners use Genostics® tests to help design personalised treatment plans and to closely monitor the effectiveness of therapies.

Specialising in the field of Oncology, we are proud to be bringing the future of personalised cancer testing to patients, today.


In this Genostics videocast, Dr. Joachim Fluhrer and Prof. Katharina Pachmann talk about Circulating Tumour Cells: what they are, their importance, and how to detect them.

In this Genostics videocast, Dr. Joachim Fluhrer and Prof. Katharina Pachmann discuss the detection of Circulating Tumour Cells (CTCs), the metastisising populatin of cancer cells, in the blood stream.

On this Genostics videocast, Dr. Joachim Fluhrer and Prof. Katharina Pachmann discuss the relevance of Circulating Tumour Cells in the bloodstream.

In this Genostics videocast, Dr. Joachim Fluhrer and Prof. Katharina Pachmann discuss the science of Maintrac technology for counting and analysing Circulating Tumour Cells.

In this Genostics videocast, Dr. Joachim Fluhrer and Prof. Katharina Pachmann discuss the clinical utility of Maintrac Circulating Tumour Cell testing.

On this Genostics videocast, Dr. Joachim Fluhrer and Prof. Katharina Pachmann discuss the scientific validation of Maintrac CTC testing.


 

News!


24 Sept 2015

Dr. Joachim Fluhrer will be presenting at the World CTC Symposium in Melbourne on 10 October 2015. Genostics will be available for general enquiries in the exhibition hall.


5 August

Your lifestyle is an on/off switch for your genes ...Find out more


June 30, 2015

Detecting the rare, renaged cancer cells ...Learn more


June 18, 2015

Survival of the fittest in cancer ...Quick view of this blog


June 8, 2015

JAMA Oncology:
"Even if surgery, chemotherapy, or radiation removes all traces of known cancer, there is still a risk of the cancer returning, often in a distant location in the body. This may occur as a result of CTCs."
...Read the article


June 2, 2015

Which chemotherapy kills the cells which cause cancer spread, doctor? ...more info


May 18, 2015

Gene expression and the regulation of genes ...Read this article


May 11, 2015

Genetics, explained simply ...Read this blog


May 5, 2015

What is a biomarker, and how are CTCs both defined as biomarkers and carriers of biomarkers? ...Learn more


April 27, 2015

Circulating Tumour Cells: Tell me more ...Quick view


April 20, 2015

How cancer spreads: The biology of metastasis ...Learn more

April 13, 2015

DNA, Cancer, and what it takes for a cell to become cancerous ...Read more


March 2015

Circulating Tumour Cell Blog

Welcome to the world's first Circulating Tumour Cell blog - written for practitioners and their patients.


 

February 2015

Cancer Deconstructed

Dr. Fluhrer gives NewYou an in-depth look at the intertwined world of cancer testing and molecular medicine.

"In what specific ways can personalised cancer testing and molecular medicine revolutionise the way people treat and think of cancer?

Every person is a separate individual, similarly every cancer is also ‘individual’ to the person affected, in a manner of speaking; cancer is heterogeneous. Cells in a malignant tumour can include cancer stem cells, promoter cells, communication cells, supportive cells, immune cells etc. Some of the cancer cells produce proteins that inhibit the immune system to recognise them and kill it."
...Read the rest of this article

December 2014


'Best of the best' publication

Prof. Pachmann's poster, outlining the use of Maintrac® technology in uncovering the heterogenous nature of Circulating Tumour Cells, was awarded 'The best of the best' poster at the Clinical Oncology Society of Australia conference. Somatic mutations of the EGFR, KRAS and BRAF genes: homogeneitiy in single cells from cell lines and heterogeneity in Circulating Epithelial Tumor Cells (CETCs) as determined using cobas® z480 analyzer (2014) ...Quick view